WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Laurent Fischer, M.D. has been added to Panacos’ Board of Directors, bringing the total number of Panacos Directors to seven.
